Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: A cross-sectional study.

Autor: Ellis CN; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan., Neville SJ; Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan., Sayyouh M; Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan., Elder JT; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan., Nair RP; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan., Gudjonsson JE; Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan., Ma T; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan., Kazerooni EA; Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan; Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan., Rubenfire M; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan., Agarwal PP; Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: prachia@umich.edu.
Jazyk: angličtina
Zdroj: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. 535-543. Date of Electronic Publication: 2021 Oct 19.
DOI: 10.1016/j.jaad.2021.09.069
Abstrakt: Background: Patients with psoriasis have elevated risk of coronary artery disease.
Objective: Do patients with severe psoriasis have larger epicardial adipose tissue volumes (EAT-V) that are associated with cardiovascular risk?
Methods: For this cross-sectional study, we recruited dermatology patients with severe psoriasis and control patients without psoriasis or rheumatologic disease themselves or in a first-degree relative. Participants aged 34 to 55 years without known coronary artery disease or diabetes mellitus underwent computed tomography (CT); EAT-V was obtained from noncontrast CT heart images.
Results: Twenty-five patients with psoriasis (14 men, 11 women) and 16 controls (5 men, 11 women) participated. Groups had no statistical difference in age, body mass index, various cardiovascular risk factors (except high-sensitivity C-reactive protein in men), CT-determined coronary artery calcium scores or plaque, or family history of premature cardiovascular disease. Mean EAT-V was greater in the psoriasis group compared to controls (P = .04). There was no statistically significant difference among women; however, male patients with psoriasis had significantly higher EAT-V than controls (P = .03), even when corrected for elevated high-sensitivity C-reactive protein (P = .05).
Limitations: A single-center convenience sample may not be representative.
Conclusion: Males with psoriasis without known coronary disease or diabetes had greater EAT-V than controls. EAT-V may be an early identifier of those at increased risk for cardiovascular events.
Competing Interests: Conflict of interest Drs Ellis, Elder, and Gudjonsson have served as consultants to various manufacturers of pharmaceuticals for psoriasis. Drs Neville, Sayyouh, Nair, Kazerooni, Rubenfire, and Agarwal and Author Ma have no conflicts of interest to disclose.
(Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: